Global CHA Network

CHA Medical Group

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No	Patent Grants
31	[KR] Cell therapy product for cartilage damage comprising collagen, hyaluronic acid derivative and mammalian umbilical cord-derived stem cells (Registration number 10-1422689)
30	[KR] Composition for skin regeneration by using medium or secretion of embryonic stem cell derived endothelial progenitor cells and use thereof (Registration number 10-1422690)
29	[KR] Composition for skin regeneration by using medium or secretion of cord blood derived endothelial progenitor cells(CB-EPCs) and use thereof (Registration number 10-1422453)
28	[KR] Method for expansion and purification of human embryonic stem cell-derived cardiomyocyte (Registration number 10-1364965)
27	[KR] Injection needle for injecting stem cells and syringe equipped therewith (Registration number 10-1322673)
26	[KR] Process for preparing lymphocytes comprising activated natural killer cells for targeting cancer cells and pharmaceutical composition comprising the same
25	[KR] System for operating stem cell bank by using internet and method thereof (Registration number 10-1295803)
24	[KR] Cosmetic composition comprising growth factor and cytokine induced human placenta (Registration number 10-1289062)
23	[KR] Pharmaceutical composition for preventing or treating gastrointestinal damage comprising kauran derivatives (Registration number 10-1282003)
22	[KR] Cosmetic composition comprising hydrolysate of silkworm silkgland and thereof (Registration number 10-1252538)